BioAge Labs (BIOA) Cash from Operations (2023 - 2026)

BioAge Labs has disclosed Cash from Operations across 4 years of filings, most recently posting 24046000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 24046000.0, down 38.49% year-over-year; the trailing twelve-month figure through Mar 2026 was 88310000.0 (down 65.96% YoY), and the FY2025 annual result was 81627000.0, down 58.43% from the prior year.
• Cash from Operations came in at 24046000.0 for Q1 2026 at BioAge Labs, up from 28251000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 5138000.0 in Q4 2024 to a low of 28251000.0 in Q4 2025.
• The 4-year median for Cash from Operations is 15912500.0 (2024), against an average of 16569800.0.
• Across the five-year window, Cash from Operations soared 39.57% in 2024 and plunged 449.84% in 2025, its largest moves.
• BioAge Labs' Cash from Operations stood at 8503000.0 in 2023, then jumped by 39.57% to 5138000.0 in 2024, then slumped by 449.84% to 28251000.0 in 2025, then climbed by 14.88% to 24046000.0 in 2026.
• The last three Cash from Operations figures came in at 24046000.0 (Q1 2026), 28251000.0 (Q4 2025), and 16044000.0 (Q3 2025), per Business Quant data.